Insider · CIK 0001583098
Donald W DeGolyer
Files at EBS (Emergent BioSolutions Inc.). First filing Nov 14, 2024, latest Oct 7, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EBS: Emergent BioSolutions Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | Emergent BioSolutions Inc. | $126k 17,800 shares | -14% | +59% from low-49% from high | |
| 20Weak | Emergent BioSolutions Inc. | $188k 17,801 shares | -13% | +158% from low-14% from high | |
| 31Weak | Emergent BioSolutions Inc. | $68k 7,844 shares | -5% | +109% from low-26% from high | |
| 41Moderate | Emergent BioSolutions Inc. | $273k 25,000 shares | -18% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock10b5-1 | -17,800 | $7.09 | $126k | 111,921 | 5 d ago |
| Nov 10, 2025 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock10b5-1 | -17,801 | $10.54 | $188k | 119,858 | Nov 12, 2025 |
| Aug 12, 2025 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock | -7,844 | $8.65 | $68k | 137,659 | Aug 13, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +34,403 | $0.00 | $0 | 145,503 | May 2, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,824 | $0.00 | $0 | 41,572 | May 2, 2025 |
| Nov 12, 2024 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock | -25,000 | $10.91 | $273k | 111,100 | Nov 14, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.